VEEV
Veeva Systems Inc
$275.09-3.27%
Setup
No setup
Buy Zone
$265.27-$278.53
Sector
Health Information Services
Industry
Health Information Services
55
Recommendation
Extended
Avoid
Setup may be valid but price is no longer in a clean buy zone.
VEEV chart
Loading chart…
ADX
Developing25.8Long Term
Range →Intermediate Term
Range →Short Term
Up ↑Overall Quality55
RS Rating
38
relative strength
Fundamentals
77
Strong fund-Q
Volume Demand
45
-45% vs avg
Technical Setup
50
4/8 checks
Industry/Theme
91
Health Information Services
Trade Plan
Extended
Entry
$265.27
Entry Zone
$265.27-$278.53
Stop / Risk
$244.05
RS Rating
38
Volume confirmed
No
Targets
$318.32 / $331.59
Breakout · IBD Setup
3 ✓ 5 ✗
Entry $265.27–$278.53Stop $244.05Target $318.32 / $331.59
Market regimeUptrend
Quality55
RS Rating38
Above 50-MA+25.04%
Above 200-MA+38.5%
VolumeWeak
In Buy ZoneNo
Not extendedExtended
Invalidation · Close below stop
How this came together
55
MarketUptrend
SetupNo setup
ConfidenceExperimental · not backtested
Fund-Q77 · Strong
StatusAvoid
Stock Data
52-Week Range148 – 310
Price % Chg YTD23.23%
Price % Chg 4wk26.3%
50-Day Avg Vol2.1 Mil
P/E Ratio45.3
Market Cap$45B
SectorHealthcare
IndustryHealth Information Services
Company Fundamentals
EPS % Chg (Qtr)38.67%
Sales % Chg (Qtr)17.6%
EPS Growth 5y18.15%
Sales Growth 5y16.88%
Annual ROE14.42%
Gross Margin74.83%
Operating Margin29.93%
Net Margin29.34%
Debt / Equity0.02
Setup levels
Current price
$275.09
Pivot
$265.27
Distance to buy
-11.4%
52-week range
148.05-310.49
Trigger evidence
No active trigger evidence available.
Financial health checks
4/5
Return on equity above 15%
ROE 14.42%
Net margin above 10%
Net margin 29.34%
EPS growing quarter on quarter
EPS q/q 38.67%
Sales growing quarter on quarter
Sales q/q 17.6%
Debt to equity below 1.0
D/E 0.02
Key metrics
Finviz snapshot · value vs. sector median (≥5 peers)
Annual ROE14.42%
vs sector -7.7%
Net margin29.34%
vs sector +12.3%
Gross margin74.83%
vs sector +8.2%
EPS growth q/q38.67%
vs sector +30.7%
Sales growth q/q17.6%
vs sector -0.9%
Debt / equity0.02
vs sector -0.62
Business quality
77
GradeStrong
EPS rating63
P/E45.3
Market cap$45B
IndustryHealth Information Services
Technical checks
Über 50-MA
Pass
Über 200-MA
Pass
RS-Linie auf neuem Hoch
Fail
Volumen bestätigt
Fail
In Kaufzone
Fail
Nicht überextended
Fail
Über 21-EMA
Pass
Volumen gesund
Pass
IBD / source mentions
No recent IBD mention found for this ticker.
Signal history
Added to list
2026-09-01
Trigger date
—
Days on list
6
Data sources: internal CANSLIM engine · Finviz snapshot · TradingView chart. Not investment advice.